$307.42
1.34% today
NYSE, Aug 22, 10:13 pm CET
ISIN
US91324P1021
Symbol
UNH

UnitedHealth Stock price

$307.42
+22.29 7.82% 1M
-154.10 33.39% 6M
-198.44 39.23% YTD
-271.30 46.88% 1Y
-237.15 43.55% 3Y
-1.42 0.46% 5Y
+196.99 178.38% 10Y
+256.06 498.56% 20Y
NYSE, Closing price Fri, Aug 22 2025
+4.07 1.34%

Key metrics

Basic
Market capitalization
$274.7b
Enterprise Value
$321.9b
Net debt
$47.2b
Cash
$32.0b
Shares outstanding
907.1m
Valuation (TTM | estimate)
P/E
13.0 | 13.6
P/S
0.6 | 0.6
EV/Sales
0.8 | 0.7
EV/FCF
12.7
P/B
2.7
Dividends
DPS
$8.18
Yield 1Y | 5Y
2.7% | 1.4%
Growth 1Y | 5Y
12.2% | 14.6%
Payout 1Y | 3Y
52.7% | 36.1%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$422.8b | $453.6b
EBITDA
$35.0b | $26.5b
EBIT
$30.8b | $22.9b
Net Income
$21.3b | $20.2b
Free Cash Flow
$25.3b
Growth (TTM | estimate)
Revenue
9.7% | 13.3%
EBITDA
-2.9% | -27.2%
EBIT
-4.0% | -29.0%
Net Income
51.0% | 40.5%
Free Cash Flow
325.7%
Margin (TTM | estimate)
Gross
-
EBITDA
8.3% | 5.8%
EBIT
7.3%
Net
5.0% | 4.5%
Free Cash Flow
6.0%
Financial Health
Equity Ratio
31.1%
Return on Equity
15.6%
ROCE
10.2%
ROIC
-
Debt/Equity
0.8
More
EPS
$23.4
FCF per Share
$27.9
Short interest
1.7%
Employees
400k
Rev per Employee
$1.0m
Show more

Create a Free Account to create an UnitedHealth alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

UnitedHealth Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a UnitedHealth forecast:

22x Buy
69%
6x Hold
19%
4x Sell
13%

Analyst Opinions

32 Analysts have issued a UnitedHealth forecast:

Buy
69%
Hold
19%
Sell
13%

Financial data from UnitedHealth

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
422,818 422,818
10% 10%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 53,146 53,146
2% 2%
13%
- Research and Development Expense - -
-
-
34,977 34,977
3% 3%
8%
- Depreciation and Amortization 4,227 4,227
6% 6%
1%
EBIT (Operating Income) EBIT 30,750 30,750
4% 4%
7%
Net Profit 21,296 21,296
51% 51%
5%

In millions USD.

Don't miss a Thing! We will send you all news about UnitedHealth directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

UnitedHealth Stock News

Negative
Seeking Alpha
about 6 hours ago
I initiate my coverage on UNH with a hold rating. Despite attractive valuation, with the P/E near 2014 levels and EV/EBITDA ~30% below sector median, I prefer to wait until the pessimism clears out. My main concern is the reinstated FY 2025 guidance at much lower EPS and the DOJ scrutiny. Overall, I don't believe the headwinds are fully priced in.
Positive
24/7 Wall Street
about 7 hours ago
Key Points in This Article: Warren Buffett seeks stocks with strong fundamentals undervalued due to market fear.
Positive
Seeking Alpha
about 7 hours ago
UNH stands out among peers for its strong dividend yield, consistent FCF generation, and expected double-digit dividend growth, making it my top healthcare pick. Despite recent setbacks—poor earnings, DOJ investigation, and reputational hits—I view these as temporary, presenting a long-term buying opportunity at a bargain price. Valuation models show UNH is trading at a 31% discount to fair val...
More UnitedHealth News

Company Profile

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health services business serving the broad health care marketplace, including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the health care industry. The OptumRx segment provides pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN.

Head office United States
CEO Stephen Hemsley
Employees 400,000
Founded 1977
Website www.unitedhealthgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today